Phase II Study of Bevacizumab Plus CHOP [cyclophosphamide, doxorubicin, vincristine, prednisolone]-Rituximab in Patients With Untreated Mantle Cell Lymphoma (NHL).
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Bevacizumab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Mantle-cell lymphoma
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 15 Sep 2017 Status changed from active, no longer recruiting to completed.
- 18 Apr 2011 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.